Clinical trial
Non-Invasive Brainstem Modulation for the Treatment of Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial (RCT)
NCT04797611 is registered in ClinicalTrials.gov with Scion NeuroStim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Invasive Brainstem Modulation for the Treatment of Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial (RCT)
- Lead sponsor
- Scion NeuroStim
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 19, 2022
- Completion date
- December 6, 2024
- Enrollment
- 188 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson disease, parkinson's disease and parkinsonism